Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Specimen Handling 118Magnetic Resonance Spectroscopy 115Cyclophosphamide 98pembrolizumab 82Radiotherapy 78Nivolumab 67Cisplatin 64fludarabine 59Biopsy 55Carboplatin 53Standard of Care 45Radiosurgery 43Dexamethasone 40Gemcitabine 39Radiation 37Paclitaxel 36venetoclax 35Rituximab 35Cytarabine 35Bevacizumab 35Surveys and Questionnaires 34Doxorubicin 33fludarabine phosphate 31Temozolomide 31Radiotherapy, Intensity-Modulated 30Capecitabine 30Practice Guidelines as Topic 29Blood Specimen Collection 29Interviews as Topic 28Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × saponin QA-21V1 × 30 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡